'Stem Cells & Regenerative Medicine-2008 Meeting’ on "Molecular Embryology to Tissue Engineering & Therapeutics”

GeneExpression Systems, Inc., Hilton Garden Inn, 420 Totten Pond Road, Waltham, MA 02451 USA
April 7-8, 2008

Key words:  Cancer stem cells, reprogramming, selfprenewal, organ culture, tissue transplantation cellular therapy, progeniror cells, neural stem cells. Biomaterilas, tissue scaffolds

'A Unique Theme to Meeting to Combine Stem Cell Discovery with Organ Regeneration'

Topics or Highlights of the Meeting:

Cell Differentiation and Reprogramming

Self-renewal and Maintenance

Human & Cancer Stem Cells & Propagation

Transcriptional Controls of Stem Cells

Applications of Stem Cells in Human Diseases

Tissue Organ Culture and Transplantation

Biopolymer Applications in Tissue Engineering

Stem Cells towards Developing Drugs & Therapeutics

Tumor Stem Cells: Uses in Drug Discovery

Transplantation of Progenitor Cell/MMP2- Polymer Constructs

Target audience:              

Executives, Directors and Scientists of R&D from biotech and pharmaceuticals.            

Graduate students, Post-docs, and Professors from Academia.              

Investors, Thought leaders and Business Development people in life sciences who need to know

 the emerging technologies.

Organizers: Krishnarao Appasani (GeneExpression Systems, Inc.); Nagy Habib (Imperial College of London, UK), Ulrich Hoffmueller (Epiontis GmbH, Berlin, Germany)           

Keynote Speakers: Dr. Ole Isacson (Harvard), Harvey F. Lodish (MIT)

Speakers include: Laurie Jackson-Grusby of Harvard Stem Cell Inst, Budd Tucker of Schepens Eye Inst. Howard Leonhardt of Bioheart, David Harris of University of Arizona, Lilian Wikstrom of Neuronova, Sweden, Sean Wu of Mass General Hospital, Tasneem Zahir of University of Toronto, Canada, A. Fawad Faruqi of Corning, Tan Ince of Brigham and Women’s Hospital, Dong-Woo Kim of Stem cell Inst., Korea and several biotech and pharmaceutical Communities will be speaking on the biology of RNAi and their utilizations in Target validation, drug and therapeutic development.

Registration Fee: Students; 399 US Dollars

Academia: 699 US Dollars

Industry: 1199 US Dollars